Search | TVST | ARVO Journals

Showing 1 – 20 of 235

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Glaucoma October 2024

Characteristics of a Large Database of Healthy Eyes From Optometry Practices: Implications for a Real-World Reference Database

PDF

Donald C. Hood; Mary Durbin; Sol La Bruna; Chris Lee; Yi Sing Hsiao; Nevin W. El-Nimri; Carlos Gustavo De Moraes; Emmanouil Tsamis
TAGS: eye, optometry, screening, reading (activity)
Trans. Vis. Sci. Tech.. 2024; 13(10):8. https://doi.org/10.1167/tvst.13.10.8

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

OCT metrics for the macular region are more sensitive for detecting glaucomatous progression than OCT circumpapillary metrics

Iván Marin-Franch; Yujia Wang; Gustavo De Moraes; Ari Leshno; Aakriti Garg Shukla; Jeffrey M Liebmann; George A Cioffi; Donald C Hood; Emmanouil (Manos) Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1451.

ARVO Annual Meeting Abstract June 2024

Use of Topographical Structure–Function Agreement For Glaucoma Screening

Ari Leshno; Donald C Hood; Jeffrey M Liebmann; George A. Cioffi; Aakriti Garg Shukla; Yonatan Shalamaev; Raam Hasharoni; Zvia Burgansky-Eliash; Alon Skaat; Emmanouil (Manos) Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2518.

ARVO Annual Meeting Abstract June 2024

Eyes with particular patterns of retinal ganglion cell damage at baseline are more likely to show glaucomatous progression

Grace Mao; Yujia Wang; Elizabeth Ahn; Ari Leshno; Gustavo De Moraes; Aakriti Garg Shukla; George A Cioffi; Jeffrey M Liebmann; Donald C Hood; Emmanouil Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2517.

ARVO Annual Meeting Abstract June 2024

Patterns of macular ganglion cell layer damage in neuro-ophthalmic disease assessed with optical coherence tomography

Mi Jeung Kim; Emmanouil Tsamis; Ari Leshno; Jeffrey Odel; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5510.

ARVO Annual Meeting Abstract June 2024

Anatomical features can affect the thickness of optical coherence tomography (OCT) measures used for clinical decisions and clinical trial endpoints

Sol La Bruna; Emmanouil Tsamis; Mary Durbin; Christopher Lee; Yi Sing Hsiao; Aziza Ganihanova; Gustavo De Moraes; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2539.

ARVO Annual Meeting Abstract June 2024

A combination of OCT metrics can detect glaucoma progression sooner than a VF benchmark criterion

Emmanouil (Manos) Tsamis; Yujia Wang; Ari Leshno; Carlos Gustavo De Moraes; Aakriti Garg Shukla; George A Cioffi; Jeffrey M Liebmann; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2537.

ARVO Annual Meeting Abstract June 2024

Characteristics of a large real-world database of healthy eyes from optometry practices: implications for a real-world reference database.

Donald C Hood; Sol La Bruna; Mary Durbin; Christopher Lee; Yi Sing Hsiao; Aziza Ganihanova; Gustavo De Moraes; Emmanouil Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2545.

Glaucoma April 2024

Anatomical Features can Affect OCT Measures Used for Clinical Decisions and Clinical Trial Endpoints

PDF

Donald C. Hood; Sol La Bruna; Mary Durbin; Chris Lee; Yi S. Hsiao; Carlos G. De Moraes; Emmanouil Tsamis
TAGS: eye, surrogate endpoints, optical coherence tomography, color
Trans. Vis. Sci. Tech.. 2024; 13(4):27. https://doi.org/10.1167/tvst.13.4.27

Includes: Supplemental Content

Glaucoma January 2024

Detecting Established Glaucoma Using OCT Alone: Utilizing an OCT Reading Center in a Real-World Clinical Setting

PDF

Ari Leshno; Emmanouil Tsamis; Sitara Hirji; Gabriel A. Gomide; Noga Harizman; Carlos Gustavo De Moraes; Aakriti Garg Shukla; George A. Cioffi; Donald C. Hood; Jeffrey M. Liebmann
TAGS: diagnostic imaging, glaucoma, reading (activity), eye
Trans. Vis. Sci. Tech.. 2024; 13(1):4. https://doi.org/10.1167/tvst.13.1.4

Perspective December 2023

A Model of Progression to Help Identify Macular Damage Due to Glaucoma

PDF

Donald C. Hood; Sol La Bruna; Ari Leshno; Gabriel A. Gomide; Mi Jeung Kim; George A. Cioffi; Jeffrey M. Liebmann; Carlos Gustavo De Moraes; Emmanouil Tsamis
TAGS: glaucoma
Invest. Ophthalmol. Vis. Sci.. 2023; 64(15):8. https://doi.org/10.1167/iovs.64.15.8

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

An evaluation of OCT and visual field measures as endpoints of glaucoma progression

Emmanouil (Manos) Tsamis; C. Gustavo De Moraes; George A Cioffi; Jeffrey M Liebmann; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4310.

ARVO Annual Meeting Abstract June 2023

Progression of advanced glaucoma is best detected at the edges of deep defects on 10-2 visual fields

Grace Mao; Gabriel Gomide; Emmanouil Tsamis; Ari Leshno; Anna J Sun; Sol La Bruna; Robert Ritch; Jeffrey M Liebmann; Gustavo De Moraes; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5493.

ARVO Annual Meeting Abstract June 2023

Understanding progression of glaucomatous damage in the central macula.

Donald C Hood; Emmanouil Tsamis; Ari Leshno; Gabriel Gomide; Sol La Bruna; George Cioffi; Jeffrey M Liebmann; C. Gustavo De Moraes

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4347.

ARVO Annual Meeting Abstract June 2023

Assessing the progression of glaucoma in the central macular region of ganglion cells using optical coherence tomography (OCT)

Gabriel Gomide; Emmanouil Tsamis; Anna Sun; Grace Mao; Sol La Bruna; Ari Leshno; George Cioffi; Jeffrey M Liebmann; C. Gustavo De Moraes; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4312.

ARVO Annual Meeting Abstract June 2023

Understanding patterns of preserved central ganglion cells in advanced glaucoma using OCT

Anna J Sun; Gabriel Gomide; Emmanouil Tsamis; Grace Mao; Ari Leshno; Sol La Bruna; Robert Ritch; Jeffrey M Liebmann; Gustavo De Moraes; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4309.

ARVO Annual Meeting Abstract June 2023

A systematic OCT-based approach can improve ophthalmology residents’ performance in glaucoma detection

Sitara Hanif Hirji; Ari Leshno; Emmanouil Tsamis; Alexis Kassotis; Anna J Sun; Gabriel Gomide; Sol La Bruna; Noga Harizman; George Cioffi; Jeffrey M Liebmann; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2015.

ARVO Annual Meeting Abstract June 2023

Focal OCT defects are predictors for future glaucoma progression in the same region

Ari Leshno; Xin Xin Xing; Emmanouil (Manos) Tsamis; Gabriel Gomide; Sol La Bruna; C. Gustavo De Moraes; George A Cioffi; Sitara Hanif Hirji; Donald C Hood; Jeffrey M Liebmann

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2023.

ARVO Annual Meeting Abstract June 2023

An OCT-Based Approach for Screening Glaucomatous Damage

Sol La Bruna; Emmanouil Tsamis; Gabriel Gomide; Justin Liu; Michael Chaglasian; Donald C Hood

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2031.

Retina May 2023

Monitoring Lesion Area Progression in Stargardt Disease: A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence

PDF

Vivienne C. Greenstein; David S. Castillejos; Stephen H. Tsang; Winston Lee; Janet R. Sparrow; Rando Allikmets; David G. Birch; Donald C. Hood
TAGS: face, fundus autofluorescence imaging, optical coherence tomography, stargardt's disease
Trans. Vis. Sci. Tech.. 2023; 12(5):2. https://doi.org/10.1167/tvst.12.5.2

Includes: Supplemental Content

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Characteristics of a Large Database of Healthy Eyes From Optometry Practices: Implications for a Real-World Reference Database

OCT metrics for the macular region are more sensitive for detecting glaucomatous progression than OCT circumpapillary metrics

Use of Topographical Structure–Function Agreement For Glaucoma Screening

Eyes with particular patterns of retinal ganglion cell damage at baseline are more likely to show glaucomatous progression

Patterns of macular ganglion cell layer damage in neuro-ophthalmic disease assessed with optical coherence tomography

Anatomical features can affect the thickness of optical coherence tomography (OCT) measures used for clinical decisions and clinical trial endpoints

A combination of OCT metrics can detect glaucoma progression sooner than a VF benchmark criterion

Characteristics of a large real-world database of healthy eyes from optometry practices: implications for a real-world reference database.

Anatomical Features can Affect OCT Measures Used for Clinical Decisions and Clinical Trial Endpoints

Detecting Established Glaucoma Using OCT Alone: Utilizing an OCT Reading Center in a Real-World Clinical Setting

A Model of Progression to Help Identify Macular Damage Due to Glaucoma

An evaluation of OCT and visual field measures as endpoints of glaucoma progression

Progression of advanced glaucoma is best detected at the edges of deep defects on 10-2 visual fields

Understanding progression of glaucomatous damage in the central macula.

Assessing the progression of glaucoma in the central macular region of ganglion cells using optical coherence tomography (OCT)

Understanding patterns of preserved central ganglion cells in advanced glaucoma using OCT

A systematic OCT-based approach can improve ophthalmology residents’ performance in glaucoma detection

Focal OCT defects are predictors for future glaucoma progression in the same region

An OCT-Based Approach for Screening Glaucomatous Damage

Monitoring Lesion Area Progression in Stargardt Disease: A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence

To View More...

You must be signed into an individual account to use this feature.